Synthetic Production of Beer Hops May Help Develop Drugs to Fight Diseases

The compounds humulones, which are alpha acids and lupulones, which are beta acids have equally important biological effects.

Beer contain little cone-shaped buds called Hops, which give beer its bitter flavor. These have several health benefits and are widely studied for their ability to halt bacterial growth and disease.

Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.

Beer Compound Could Lead to New Drugs
Humulones derived from hops which give beer its distinctive flavor could lead to new drugs for diabetes and some types of cancers, say researchers.

‘Researchers are trying to synthesize beer compounds called humulones and lupulones in the lab, which may help in developing drugs in the future.’

The researchers present their work today at the 251st National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world's largest scientific society, is holding the meeting here through Thursday. It features more than 12,500 presentations on a wide range of science topics.

"When researchers extract healthful chemicals from hops, they first have to determine whether they have separated out the specific compounds they're interested in," says Kristopher Waynant, who leads the project. "But if you can figure out how to make these compounds from scratch, you know they are the right ones."

The compounds Waynant is interested in are humulones, which are alpha acids that have anticancer and anti-inflammatory properties, and lupulones, which are beta acids that have equally important but not as well-understood biological effects. Scientists ultimately want to harness these activities to potentially improve human health. But before humulones and lupulones can be turned into effective pharmaceuticals, scientists must confirm that they are extracting the proper acids from hops. In theory, they can do this by separating the acids with high performance liquid chromatography, but results from this method need to be compared to analytical standards, which do not yet exist for the individual compounds.

In order to create a library of such analytical standards, Waynant and undergraduate student Lucas Sass, both at the University of Idaho, are attempting to synthesize a set of humulones and lupulones in the lab.

Beer Ingredient Protects Brain Cells from Damage and Helps Fight Alzheimer's, Parkinson's Disease
An ingredient from beer, called xanthohumol, could protect brain cells from damage and potentially slow the development of brain disorders.

The researchers start with phloroglucinol - a commercially available compound that is derived from plants. So far, they have been developing multi-step processes to synthesize three types of humulones. They begin with acylation and prenylation steps, and then use transition-metal catalysis with a chiral ligand to create asymmetric products. The team is still working on tweaking the final step of converting the intermediate products in the desired humulones efficiently.

"Unfortunately, the first few pathways I proposed were not the best or most efficient," Waynant admits. "But Lucas has gone through the literature and analyzed different ways to perform each of these steps to get the best results."

Drinking Belgian Beer and Coffee may Actually Help You Reduce Weight
Microbes make up 90% of living cells in our bodies and when disrupted may show unfavorable effects on metabolism leading to weight gain and obesity.

Currently, Sass is making progress on optimizing the first two steps. "It's been a lot of trial and error," Sass says. "But it's so exciting when an approach finally works."

The researchers say they are getting very close to optimizing the complete method for producing humulones in the lab.

Drinking Over a Liter of Beer Increases Exposure to Deadly Mycotoxins
People who drink more than a liter of beer are exposed to toxic metabolites that contain concentrations of DON and HT-2 that often exceed safety levels.

In the future, Waynant's team will continue the project to synthesize a broader range of humulones and lupulones. He also plans to reach out to and collaborate with biologists and medical researchers to develop active agents for pharmaceuticals to treat cancers or inflammatory diseases from these beer-inspired compounds.

Source-Newswise